Answers are grounded in this paper and cite their sources.
Investigates FEV1 levels and nitric oxide in smokers versus non-smokers, indicating reduced lung function in smokers.
The study aim was to investigate pre- and post-exercise FEV 1 level and the level of total NO 3 -/ NO 2 - in exhaled breath condensate (EBC) in smokers compared to non-smokers. The control group included healthy non-smokers aged 18 - 35 years (those with no diagnosed respiratory diseases). The second group included current smokers aged 18 - 35 years (smoking history of ≥ 3 years) without respiratory pathology. Both groups were studied at rest, post-exercise FEV 1 level was also measured after 10 minutes jogging. The 1.6-fold reduced basal level of NO metabolites in EBC was found in smokers compared to non-smokers (1,42 ± 0,11 mkmol/l and 2,4 ± 0,26 mkmol/l respectively, p <0.05). Significant differences in post-exercise FEV 1 level in smokers and non-smokers were not observed probably due to the small smoking history. Nevertheless, post-exercise FEV 1 level in smokers was 1.3-fold lower than in non-smoking group. Thus, in healthy smokers the reduced respiratory functional capacity was found to be associated with impaired NO synthesis in the lungs even at relatively small smoking history.
No takes yet. Share an insight, caveat, or question.
Zaprudnova et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: